Oxytocin protocols for cesarean delivery

International Anesthesiology Clinics

Volumn 52, Issue 2, 2014, Pages 48-66

  Balki, Mrinalini ^a   Tsen, Lawrence ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; OXYTOCIN; OXYTOCIN RECEPTOR; OXYTOCIC AGENT;

ADVERSE OUTCOME; ARTICLE; CARDIOVASCULAR RISK; CESAREAN SECTION; COMA; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG RECEPTOR BINDING; HEART HEMODYNAMICS; HUMAN; HYPONATREMIA; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SEIZURE; SPINAL ANESTHESIA; UTERUS CONTRACTILITY; WATER RETENTION; CLINICAL PROTOCOL; FEMALE; PREGNANCY; PROCEDURES;

CESAREAN SECTION; CLINICAL PROTOCOLS; FEMALE; HUMANS; OXYTOCICS; OXYTOCIN; PREGNANCY;

EID: 84897489612     PISSN: 00205907     EISSN: 15371913     Source Type: Journal    
DOI: 10.1097/AIA.0000000000000016     Document Type: Article

References (64)

1. Engstrom T. Myometrial receptors in rat parturition. Dan Med Bull. 2002;50: 219-237. (Pubitemid 37047327)
2. Dale HH. "On some physiological actions of ergot". J Physiol. 1906;34:163-206.
3. du Vigneaud V, Ressler C, Swan JM, et al. The synthesis of an octapeptide amide with the hormonal activity of oxytocin. J Am Chem Soc. 1953;75:4879-4880.
4. Caldeyro-Barcia R, Poseiro JJ. Oxytocin and contractility of the pregnant human uterus. Ann N Y Acad Sci. 1959;75:813-830.
5. Caldeyro-Barcia R. Oxytocin in pregnancy and labour. Acta Endocrinol Suppl (Copenh). 1960;34:41-49.
6. Zeeman GG, Khan-Dawood FS, Dawood MY. Oxytocin and its receptor in pregnancy and parturition: current concepts and clinical implications. Obstet Gynecol. 1997; 89:873-883. (Pubitemid 27184837)
7. Inoue T, Kimura T, Azuma C, et al. Structural organization of the human oxytocin receptor gene. J Biol Chem. 1994;269:32451-32456.
8. Michelini S, Urbanek M, Dean M, et al. Polymorphism and genetic mapping of the human oxytocin receptor gene on chromosome 3. Am J Med Genet. 1995;60:183-187.
9. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001;81:629-683. (Pubitemid 32267075)
10. Kimura T, Takemura M, Nomura S, et al. Expression of oxytocin receptor in human pregnant myometrium. Endocrinology. 1996;137:780-785. (Pubitemid 26043774)
11. Garfield RE. Control of myometrial function in preterm versus term labor. Clin Obstet Gynecol. 1984;27:572-591. (Pubitemid 14043383)
12. Leake RD, Weitzman RE, Fisher DA. Pharmacokinetics of oxytocin in the human subject. Obstet Gynecol. 1980;56:701-704. (Pubitemid 11216939)
13. Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev. 2013;(issue 10): Art. No.: CD001808.
14. Prendiville WJP, Elbourne D, McDonald SJ. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev. 2000;(issue 3):Art. No.: CD000007.
15. McDonald SJ, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev. 2004;(issue 1):Art. No.: CD000201.
16. WHO guidelines for the management of postpartum haemorrhage and retained placenta; 2009. Available at: http://whqlibdoc.who.int/publications/2009/ 9789241598514-eng.pdf. Accessed July 15, 2013.
17. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006;108:1039-1047.
18. Royal College of Obstetricians and Gynaecologists: prevention and management of postpartum haemorrhage. RCOG Green-top Guideline No. 52; May 2009. Available at: http://www.rcog.org.uk/files/rcog-corp/ GT52PostpartumHaemorrhage0411.pdf. Accessed September 24, 2012.
19. Leduc D, Senikas V, Lalonde AB, et al. Clinical Practice Obstetrics Committee; Society of Obstetricians and Gynaecologists of Canada. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage: no. 235 October 2009 (replaces no. 88, April 2000). J Soc Obstet Gynaecol Can. 2009;31: 980-993.
20. Sheehan SR, Wedisinghe L, Macleod M, et al. Implementation of guidelines on oxytocin use at caesarean section: a survey of practice in Great Britain and Ireland. Eur J Obstet Gynecol Reprod Biol. 2010;148:121-124.
21. Mockler JC, Murphy DJ, Wallace EM. An Australian and New Zealand survey of practice of the use of oxytocin at elective caesarean section. Aust N Z J Obstet Gynaecol. 2010;50:30-35.
22. Sarna MC, Soni AK, Gomez M, et al. Intravenous oxytocin in patients undergoing elective cesarean section. Anesth Analg. 1997;84:753-756. (Pubitemid 27147696)
23. Carvalho JC, Balki M, Kingdom J, et al. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol. 2004;104:1005-1010. (Pubitemid 40458764)
24. Butwick AJ, Coleman L, Cohen SE, et al. Minimum effective bolus dose of oxytocin during elective Caesarean delivery. Br J Anaesth. 2010;104:338-343.
25. George RB, McKeen D, Chaplin AC, et al. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery. Can J Anaesth. 2010;57:578-582.
26. Munn MB, Owen J, Vincent R, et al. Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2001;98:386-390.
27. Balki M, Ronayne M, Davies S, et al. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol. 2006;107:45-50.
28. Crane JMG, Young DC. Meta-analysis of low dose versus high dose oxytocin for labour induction. J Soc Obstet Gynaecol Can. 1998;20:1215-1223.
29. Grotegut CA, Paglia MJ, Johnson LNC, et al. Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atony. Am J Obstet Gynecol. 2011;204:e1-e6.
30. Balki M,Dhumne S, Kasodekar S, et al.Oxytocin-ergometrine co-administration does not reduce blood loss at caesarean delivery for labour arrest. BJOG. 2008;115:579-584. (Pubitemid 351357574)
31. Sheehan SR, Montgomery AA, Carey M, et al. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial. BMJ. 2011;343:d4661.
32. Phaneuf S, Asboth G, Carrasco MP, et al. Desensitization of oxytocin receptors in human myometrium. Hum Reprod Update. 1998;4:625-633. (Pubitemid 29041476)
33. Smith MP, Ayad VJ, Mundell SJ, et al. Internalization and desensitization of the oxytocin receptor is inhibited by dynamin and clathrin mutants in human embryonic kidney 293 cells. Mol Endocrinol. 2006;20:379-388. (Pubitemid 43152511)
34. Robinson C, Schumann R, Zhang P, et al. Oxytocin-induced desensitization of the oxytocin receptor. Am J Obstet Gynecol. 2003;188:497-502. (Pubitemid 36249992)
35. Phaneuf S, Rodriguez Linares B, TambyRaja RL, et al. Loss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmented labour. J Reprod Fertil. 2000;120:91-97.
36. Magalhaes JK, Carvalho JC, Parkes RK, et al. Oxytocin pretreatment decreases oxytocin-induced myometrial contractions in pregnant rats in a concentrationdependent but not time-dependent manner. Reprod Sci. 2009;16:501-508.
37. Balki M, Erik-Soussi M, Kingdom J, et al. Oxytocin pretreatment attenuates oxytocininduced contractions in human myometrium in-vitro. Anesthesiology. 2013;119:552-561.
38. Balki M, Erik-Soussi M, Kingdom J, et al. Myometrial contractility with different uterotonic agents in laboring and non-laboring women. Society for Obstetric Anesthesia and Perinatology Meeting, San Antonio, Texas, USA, May 12-18, 2010. 2010:A128.
39. Balki M, Cristian AL, Kingdom J, et al. Oxytocin pretreatment of pregnant rat myometrium reduces the efficacy of oxytocin but not of ergonovine maleate or prostaglandinF2 alpha. Reprod Sci. 2010;17:269-277.
40. Thomas TA, Cooper GM. Maternal deaths from anaesthesia. An extract from why mothers die 1997-1999, the confidential enquiries into maternal deaths in the United Kingdom. Br J Anaesth. 2002;89:499-508. (Pubitemid 34993983)
41. Saving Mothers 2005-2007: fourth report on Confidential Enquiries into Maternal Deaths in South Africa. Available at: http://www.health.gov.za/docs/ reports/2011/saving-b.pdf. Accessed July 20, 2013.
42. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary. 54th ed. London: BMJ Publishing Group and APS Publishing: 2007;413-416. Available at: http://www.bnf.org/.
43. Secher NJ, Arnsbo P, Wallin L. Haemodynamic effects of oxytocin (syntocinon) and methyl ergometrine (methergin) on the systemic and pulmonary circulations of pregnant anaesthetized women. Acta Obstet Gynecol Scand. 1978;57:97-103. (Pubitemid 8291970)
44. Thibonnier M, Conarty DM, Preston JA, et al. Human vascular endothelial cells express oxytocin receptors. Endocrinology. 1999;140:1301-1309. (Pubitemid 29104234)
45. Petersson M. Cardiovascular effects of oxytocin. Prog Brain Res. 2002;139:281-288. (Pubitemid 35460897)
46. Mukaddam-Daher S, Yin YL, Roy J, et al. Negative inotropic and chronotropic effects of oxytocin. Hypertension. 2001;38:292-296. (Pubitemid 34224760)
47. Pinder AJ, Dresner M, Calow C, et al. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth. 2002;11:156-159. (Pubitemid 34836288)
48. Langesæter E, Rosseland LA, Stubhaug A. Hemodynamic effects of oxytocin during cesarean section. Int J Gynaecol Obstet. 2006;95:46-47. (Pubitemid 44310666)
49. Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. Br J Anaesth. 2007;98:116-119. (Pubitemid 44896761)
50. Svanstrom MC, Biber B, Hanes M, et al. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. Br J Anaesth. 2008;100:683-689. (Pubitemid 351774375)
51. Sartain JB, Barry JJ, Howat PW, et al. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section. Br J Anaesth. 2008;101: 822-826.
52. Langesæter E, Rosseland LA, Stubhaug A. Haemodynamic effects of repeated doses of oxytocin during Caesarean delivery in healthy parturients. Br J Anaesth. 2009;103:260-262.
53. Jonsson M, Hanson U, Lidell C, et al. ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial. BJOG. 2010;117:76-83.
54. McLeod G, Munishankar B, MacGregor H, et al. Maternal haemodynamics at elective caesarean section: a randomised comparison of oxytocin 5-unit bolus and placebo infusion with oxytocin 5-unit bolus and 30-unit infusion. Int J Obstet Anesth. 2010;19:155-160.
55. Kim TS, Bae JS, Park JM, et al. Hemodynamic effects of continuous intravenous injection and bolus plus continuous intravenous injection of oxytocin in cesarean section. Korean J Anesthesiol. 2011;61:482-487.
56. Langesæter E, Rosseland LA, Stubhaug A. Haemodynamic effects of oxytocin in women with severe preeclampsia. Int J Obstet Anesth. 2011;20:26-29.
57. Bhattacharya S, Ghosh S, Ray D, et al. Oxytocin administration during cesarean delivery: randomized controlled trial to compare intravenous bolus with intravenous infusion regimen. J Anaesthesiol Clin Pharmacol. 2013;29:32-35.
58. Dyer R, Reed A, van Dyk D, et al. Hemodynamic effects of ephedrine, phenylephrine, and the coadministration of phenylephrine with oxytocin during spinal anesthesia for elective cesarean delivery. Anesthesiology. 2009;111:753-765.
59. Dyer RA, Piercy JL, Reed AR, et al. Hemodynamic changes associated with spinal anesthesia for cesarean delivery in severe preeclampsia. Anesthesiology. 2008;108:802-811. (Pubitemid 351589475)
60. Langesæter E, Dragsund M, Rosseland LA. Regional anaesthesia for Caesarean section in women with cardiac disease: a prospective study. Acta Anaesthesiol Scand. 2010;54:46-54.
61. Bergum D, Lonne H, Hakli TF. Oxytocin infusion: acute hyponatraemia, seizures and coma. Acta Anaesthesiol Scand. 2009;53:826-827.
62. Abdul-Karim R, Assali NS. Renal function in human pregnancy. V. Effects of oxytocin on renal hemodynamics and water and electrolyte excretion. J Lab Clin Med. 1961;57:522-532.
63. Institute for Safe Medical Practices. High alert medications. Available at: http://www.Ismp.org. Accessed July 20, 2013.
64. Tsen L, Balki M. Oxytocin protocols during cesarean delivery: time to acknowledge the risk/benefit ratio? Int J Obstet Anesth. 2010;19:243-245.